Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Townsend

Showing results (291-300 of 312) with videos related to

Pageof 32
Sort By:
Cell Reports. Medicine|September 20, 2023
Combination of an ACLY inhibitor with a GLP-1R agonist exerts additive benefits on nonalcoholic steatohepatitis and hepatic fibrosis in miceEric M Desjardins, Jianhan Wu, Declan C T Lavoie, et al.
British Journal of Cancer|June 27, 2026
Ovarian cancer tumor immune profiles associated with intrauterine device and oral contraceptive useJennifer M Mongiovi, Ana Babic, Naoko Sasamoto, et al.
Cell Reports|November 27, 2025
Inhibiting peripheral serotonin activates liver AMPK and reduces monocyte-derived macrophages and fibrosisBattsetseg Batchuluun, Tinne Thoné, Andre Djalalvandi, et al.
Cancers|July 14, 2023
Relationships among Inflammatory Biomarkers and Self-Reported Treatment-Related Symptoms in Patients Treated with Chemotherapy for Gynecologic Cancer: A Controlled ComparisonAasha I Hoogland, Brent J Small, Laura B Oswald, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2019
Reproductive and Hormonal Factors and Risk of Ovarian Cancer by Tumor Dominance: Results from the Ovarian Cancer Cohort Consortium (OC3)Tianyi Huang, Mary K Townsend, Nicolas Wentzensen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2000
Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: improved safety and high titerP L Sheridan, M Bodner, A Lynn, et al.
Cancers|August 12, 2023
Relationships among Inflammatory Biomarkers and Objectively Assessed Physical Activity and Sleep during and after Chemotherapy for Gynecologic MalignanciesDanielle B Tometich, Aasha I Hoogland, Brent J Small, et al.
Cell Metabolism|January 7, 2026
Dual inhibition of ACLY and ACSS2 by EVT0185 reduces steatosis, hepatic stellate cell activation, and fibrosis in mouse models of MASHFiorella Di Pastena, Jaya Gautam, James S V Lally, et al.
Nature|February 4, 2021
IgA transcytosis and antigen recognition govern ovarian cancer immunitySubir Biswas, Gunjan Mandal, Kyle K Payne, et al.
Frontiers in Immunology|January 5, 2026
Chronic stress drives ovarian cancer progression via myeloid-derived suppressor cells infiltration and Notch signaling pathway activationYadiel A Rivera-López, Alanis P Torres-Rosado, Jaydiel A Casiano-Martínez, et al.
Pageof 32

Showing results (291-300 of 312) with videos related to

Sort By:
Pageof 32
Cell Reports. Medicine|September 20, 2023
Combination of an ACLY inhibitor with a GLP-1R agonist exerts additive benefits on nonalcoholic steatohepatitis and hepatic fibrosis in miceEric M Desjardins, Jianhan Wu, Declan C T Lavoie, et al.
British Journal of Cancer|June 27, 2026
Ovarian cancer tumor immune profiles associated with intrauterine device and oral contraceptive useJennifer M Mongiovi, Ana Babic, Naoko Sasamoto, et al.
Cell Reports|November 27, 2025
Inhibiting peripheral serotonin activates liver AMPK and reduces monocyte-derived macrophages and fibrosisBattsetseg Batchuluun, Tinne Thoné, Andre Djalalvandi, et al.
Cancers|July 14, 2023
Relationships among Inflammatory Biomarkers and Self-Reported Treatment-Related Symptoms in Patients Treated with Chemotherapy for Gynecologic Cancer: A Controlled ComparisonAasha I Hoogland, Brent J Small, Laura B Oswald, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 14, 2019
Reproductive and Hormonal Factors and Risk of Ovarian Cancer by Tumor Dominance: Results from the Ovarian Cancer Cohort Consortium (OC3)Tianyi Huang, Mary K Townsend, Nicolas Wentzensen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2000
Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: improved safety and high titerP L Sheridan, M Bodner, A Lynn, et al.
Cancers|August 12, 2023
Relationships among Inflammatory Biomarkers and Objectively Assessed Physical Activity and Sleep during and after Chemotherapy for Gynecologic MalignanciesDanielle B Tometich, Aasha I Hoogland, Brent J Small, et al.
Cell Metabolism|January 7, 2026
Dual inhibition of ACLY and ACSS2 by EVT0185 reduces steatosis, hepatic stellate cell activation, and fibrosis in mouse models of MASHFiorella Di Pastena, Jaya Gautam, James S V Lally, et al.
Nature|February 4, 2021
IgA transcytosis and antigen recognition govern ovarian cancer immunitySubir Biswas, Gunjan Mandal, Kyle K Payne, et al.
Frontiers in Immunology|January 5, 2026
Chronic stress drives ovarian cancer progression via myeloid-derived suppressor cells infiltration and Notch signaling pathway activationYadiel A Rivera-López, Alanis P Torres-Rosado, Jaydiel A Casiano-Martínez, et al.
Pageof 32